Home > Boards > US Listed > Biotechs > BioMarin Pharmaceutical Inc. (BMRN)

Direct link to the briefing materials:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
chmcnfunds Member Profile
 
Followed By 69
Posts 11,686
Boards Moderated 0
Alias Born 12/25/09
160x600 placeholder
BioMarin Pharmaceutical Q4 2020 Earnings Preview Seeking Alpha - 2/24/2021 5:35:23 PM
BioMarin to Participate in Four Upcoming Virtual Investor Conferences PR Newswire (US) - 2/24/2021 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/22/2021 4:31:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/19/2021 5:30:04 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 2/19/2021 4:36:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/18/2021 6:43:42 PM
BioMarin Appoints Former Goldman Sachs Partner and Life Sciences Executive, Maykin Ho, Ph.D. to Board of Directors PR Newswire (US) - 2/18/2021 4:01:00 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 2/12/2021 3:11:43 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/11/2021 3:42:43 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/10/2021 10:44:12 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2021 8:04:48 AM
BioMarin Earns Top Marks in Human Rights Campaign's 2021 Corporate Equality Index PR Newswire (US) - 1/28/2021 9:00:00 AM
BioMarin to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast on Thursday, February 25 at ... PR Newswire (US) - 1/26/2021 8:30:00 AM
BioMarin Announces Positive Phase 3 Gene Therapy Trial Results in Adults with Severe Hemophilia A; Study Met All Primary and ... PR Newswire (US) - 1/10/2021 6:44:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/7/2021 9:56:43 AM
BioMarin to Participate in Two Upcoming Virtual Investor Conferences PR Newswire (US) - 1/5/2021 8:30:00 AM
BioMarin Announces Benefit Maintained for Over Two Years in Children with Achondroplasia Treated with Vosoritide in Phase 3 E... PR Newswire (US) - 12/21/2020 8:29:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/18/2020 4:32:04 PM
BioMarin to Participate in Two Upcoming Virtual Investor Conferences PR Newswire (US) - 12/1/2020 8:30:00 AM
BioMarin and Deep Genomics to Collaborate on Advancing Programs Identified Using Artificial Intelligence PR Newswire (US) - 11/17/2020 8:29:00 AM
BioMarin to Participate in Three Upcoming Virtual Investor Conferences PR Newswire (US) - 11/12/2020 8:30:00 AM
BioMarin Expands Vosoritide Clinical Program PR Newswire (US) - 11/9/2020 8:31:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/6/2020 12:55:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 4:12:53 PM
BioMarin Announces Third Quarter 2020 Total Revenues of $477 Million PR Newswire (US) - 11/5/2020 4:05:00 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2021 InvestorsHub.com, Inc.
Consent Preferences